診斷放射性同位素市場：以放射性同位素、按應用、成像方式、按適應症、按最終用戶、按地區

診斷放射性同位素市場規模預計在 2025 年為 67.4 億美元，預計到 2032 年將達到 123.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 9%。

由於慢性病發病率的上升、醫學影像技術的進步以及對精準診斷程序的需求不斷成長，全球診斷放射性同位素市場正在經歷顯著成長。診斷放射性同位素是用於醫學影像診斷各種疾病和病症的放射性物質。這些放射性同位素發射的輻射可被成像儀器偵測到，使醫療專業人員能夠觀察和分析人體內部結構。

市場動態：

全球診斷放射性同位素市場的動態受多種因素影響。癌症、心血管疾病和神經病變等慢性疾病的發生率不斷上升，推動了對診斷放射性同位素的需求。這些放射性同位素用於各種成像技術，例如正子斷層掃描 (PET)、單光子發射電腦斷層掃描 (SPECT) 和伽馬攝影機，以檢測和診斷這些疾病。

然而，有幾個因素阻礙了市場的成長。診斷用放射性同位素的高成本以及對其生產和使用的嚴格監管要求，對市場成長構成了挑戰。此外，放射性同位素的供應有限，以及某些同位素的半衰期較短，也限制了它們在某些診斷程序中的應用。

儘管面臨這些挑戰，市場仍提供了許多成長機會。 PET/CT 和 SPECT/CT 等混合成像技術的日益普及預計將推動診斷放射性同位素的需求。此外，新型放射性同位素和放射性藥物的開發以及成像技術的進步預計將為市場創造新的機會。

本研究的主要特點

• 本報告對全球診斷放射性同位素市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 全球診斷放射性同位素市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球診斷放射性同位素市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過用於分析全球診斷放射性同位素市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
• 癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升
  • 限制因素
• 診斷放射性同位素高成本
  • 機會
• 混合成像技術的採用日益增多
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

4. 全球診斷放射性同位素市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 全球診斷放射性同位素市場（以放射性同位素），2020 年至 2032 年

• Technetium-99m
• 鉈-201
• 鎵-67
• 碘-123
• FDG
• 銣82
• 其他

6. 2020 年至 2032 年全球診斷放射性同位素市場（依應用）

• 診斷用途
• 治療用途

7. 2020 年至 2032 年全球診斷放射性同位素市場（以影像方式）

• SPECT
• PET
• BETA 放射體

8. 2020 年至 2032 年全球診斷放射性同位素市場（依適應症分類）

• 瘤
• 心臟病
• 神經
• 甲狀腺
• 整形外科
• 內分泌
• 其他

9. 2020 年至 2032 年全球診斷放射性同位素市場（依最終使用者分類）

• 醫院
• 專科診所
• 診斷中心
• 學術研究所
• 其他

第 10 章。 2020 年至 2032 年按地區分類的全球診斷放射性同位素市場

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第11章競爭格局

• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips NV
• Cardinal Health
• Lantheus Holdings, Inc.
• Bayer AG
• Bracco
• Eckert & Ziegler
• Nordion（Canada）Inc.
• NTP Radioisotopes
• Curium
• Jubilant Life Sciences Ltd
• IRE
• Isotopia Molecular Imaging Ltd.
• Mallinckrodt Nuclear Medicine LLC
• Jubilant DraxImage Inc.
• Sumitomo Heavy Industries, Ltd.
• Telix Pharmaceuticals Limited

第12章 章節

• 調查方法
• 關於出版商

Diagnostic Radioisotopes Market is estimated to be valued at USD 6.74 Bn in 2025 and is expected to reach USD 12.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9% from 2025 to 2032.

The global market for diagnostic radioisotopes is experiencing significant growth due to the increasing prevalence of chronic diseases, advancements in medical imaging technology, and the rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.

Market Dynamics:

The market dynamics of the global diagnostic radioisotopes market are influenced by several factors. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.

However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. Additionally, the limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.

Despite these challenges, the market presents several opportunities for growth. The increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to drive the demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.

Key features of the study:

• This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Philips Healthcare , Cardinal Health , Lantheus Medical Imaging, Bayer AG, Bracco Imaging, EczacIbasI-Monrol Nuclear Products , Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd , IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd. , Institute of Atomic Energy of Bangladesh , Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market

Detailed Segmentation:

• Global Diagnostic Radioisotopes Market, By Radioisotope
  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others
• Global Diagnostic Radioisotopes Market, By Application
  • Diagnostic Application
  • Therapeutic Application
• Global Diagnostic Radioisotopes Market, By Imaging Modality
  • SPECT
  • PET
  • Beta Emitters
• Global Diagnostic Radioisotopes Market, By End User
  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Others
• Global Diagnostic Radioisotopes Market, By Indication
  • Cardiology
  • Oncology
  • Neurology
  • Others
• Global Diagnostic Radioisotopes Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profile:
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bayer AG
  • Bracco Imaging
  • EczacIbasI-Monrol Nuclear Products
  • Nordion
  • Advanced Accelerator Applications
  • NTP Radioisotopes
  • Curium Pharma
  • Jubilant Life Sciences Ltd
  • IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares
  • Australian Nuclear Science and Technology Organisation (ANSTO)
  • Eckert & Ziegler Radiopharma GmbH
  • Isotopia Molecular Imaging Ltd.
  • Institute of Atomic Energy of Bangladesh
  • Rosatom State Atomic Energy Corporation
  • Board of Radiation and Isotope Technology (BRIT)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Diagnostic Radioisotopes, By Radioisotope
  • Market Diagnostic Radioisotopes, By Application
  • Market Diagnostic Radioisotopes, By Imaging Modality
  • Market Diagnostic Radioisotopes, By Indication
  • Market Diagnostic Radioisotopes, By End User
  • Market Diagnostic Radioisotopes, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
  • Restraints
• High cost of diagnostic radioisotopes
  • Opportunities
• Increasing adoption of hybrid imaging techniques
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Technetium-99m
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Thallium-201
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Gallium-67
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Iodine-123
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• FDG
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Rubidium-82
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Diagnostic Radioisotopes Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Diagnostic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Therapeutic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• SPECT
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• PET
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Beta Emitters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Diagnostic Radioisotopes Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Thyroid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Diagnostic Radioisotopes Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Diagnostic Radioisotopes Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,( US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lantheus Holdings, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bracco
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Eckert & Ziegler
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nordion (Canada) Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NTP Radioisotopes
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Curium
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jubilant Life Sciences Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IRE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Isotopia Molecular Imaging Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mallinckrodt Nuclear Medicine LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Jubilant DraxImage Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sumitomo Heavy Industries, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Telix Pharmaceuticals Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us